Xcopri 100 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FMXXL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,038
Award facts
- Contract value 100% obligated
- $1,037.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) valued at $1,037.97. This firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military healthcare systems through this expansive global contract vehicle, which enables the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare programs. The current delivery order for Xcopri, an anti-epileptic medication, exemplifies the company's role in supplying specialized pharmaceutical products to military medical supply chains. The DLA's Pharmaceutical Prime Vendor Global Program continues to support military healthcare operations through multiple regional contracts, with AmerisourceBergen positioned as a primary vendor for comprehensive pharmaceutical procurement needs.
Quick answers
Who was awarded contract SPE2DB25FMXXL?
SPE2DB25FMXXL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FMXXL worth?
The government has obligated $1,038 on SPE2DB25FMXXL.
Is contract SPE2DB25FMXXL an order under another contract?
Yes. SPE2DB25FMXXL is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMXXL competed?
The extent of competition for SPE2DB25FMXXL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award